Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting

Documenti analoghi

• Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
  di: Sebastiaan De Keersmaecker, et al.
  Pubblicazione: (2024)
• How can Alzheimer's disease blood‐based biomarkers reach clinical practice?
  di: Robert Perneczky, et al.
  Pubblicazione: (2025)
• Response to the letter to the editor “Blood‐based biomarkers for Alzheimer's disease in primary care: A French qualitative study exploring perspectives of general practitioners”
  di: Thomas Claessen, et al.
  Pubblicazione: (2026)
• Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
  di: Katharina Bolsewig, et al.
  Pubblicazione: (2024)
• General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
  di: Thomas Claessen, et al.
  Pubblicazione: (2025)